ThursdayMar 02, 2023 2:01 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Encouraging Results from DehydraTECH-CBD Diabetes Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its diabetes animal model study DIAB-A22-1 has completed and produced at least three positive outcomes including weight loss in obese diabetic-conditioned animals, together with improved triglyceride and cholesterol levels. According to the update, the study evidenced, at times, dramatic changes in body weight, general activity and triglyceride and cholesterol levels associated with administration of DehydraTECH-CBD. The findings align well with other study work in animals that points to the known anti-inflammatory and antioxidant properties of CBD functioning to lessen some of the essential pathophysiological factors…

Continue Reading

ThursdayMar 02, 2023 1:08 pm

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Schedules Q4 and FY 2022 Results Call

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (“VECG”) platform for heart attack detection anytime, anywhere, today announced its plans to host a conference call to discuss its results for the fourth quarter and full fiscal year ended Dec. 31, 2022. The call is scheduled to start at 4:30 p.m. Eastern Time on Thursday, March 16, 2023. HeartBeam CEO and Founder Branislav Vajdic, PhD, President Robert Eno, CFO Richard Brounstein, and CBO Jon Hunt, PhD, will review the results and discuss recent announcements, ongoing initiatives and key 2023 milestones. Interested parties should…

Continue Reading

ThursdayMar 02, 2023 12:43 pm

QualityStocksNewsBreaks – Data443 Risk Mitigation Inc.’s (ATDS) RRM Deemed One of the Best Ransomware Protections for 2023

Data443 (OTC: ATDS), a data security and privacy software company for “All Things Data Security,” today announced that PC Magazine featured Ransomware Recovery Manager (“RRM”) in its ransomware protection rankings. RRM was named “Best of Inexpensive Protection” and “Best for Kiosks” in “The Best Ransomware Protection for 2023.” “Significant efforts went into this product line revamp; it’s a real testament to our development, quality assurance and design teams,” said Jason Remillard, Data443’s founder and CEO. “Competing with the larger brands, such as [SentinelOne (NYSE: S), CrowdStrike (NASDAQ CRWD) and Varonis (NASDAQ: VRNS)], we bring something different and unique to the…

Continue Reading

ThursdayMar 02, 2023 12:32 pm

QualityStocksNewsBreaks – Sugarmade Inc. (SGMD) Names New Board, Audit Committee Member

Sugarmade (OTC: SGMD), a product and branding marketing company investing in operations and technologies with disruptive potential, has appointed Darren Kenney as a new independent director and audit committee member. In the announcement, Sugarmade noted that it is focusing on an aggressive growth strategy and is looking to Kenney and his expertise to ensure the accuracy and integrity of company financial affair. An experienced CPA and licensed real estate broker in California, Kenney has built and sold three accounting practices over the past three decade; he has also served as a consultant with GTE (now Verizon), Saks Fifth Avenue and CalTrans. “This…

Continue Reading

ThursdayMar 02, 2023 11:41 am

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Secures Contract with Overton Brooks VA Medical Center

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced that Overton Brooks Veterans Administration (“VA”) Medical Center in Shreveport, Louisiana, executed a contract for 10 new K1 Blue Light Towers. The announcement reads, “The Veterans Health Administration, an organization of the U.S. Department of Veterans Affairs, is the country’s largest integrated health care system with over 170 health care facilities across the country staffed by nearly 400,000 employees that care for over 9 million beneficiaries – the heroes that serve our country and the families that support them. It is…

Continue Reading

ThursdayMar 02, 2023 11:21 am

QualityStocksNewsBreaks – SideChannel Inc. (SDCH) CEO Featured in Interview with Forum Daily

SideChannel (OTCQB: SDCH), a provider of cybersecurity products and services to emerging, middle-market and enterprise companies, was featured in an interview segment with Forum Daily. SideChannel’s CEO and cybersecurity expert Brian Haugli joined the program to discuss privacy and security concerns surrounding TikTok as Canada joins the U.S. and other countries in banning the app from government devices. “This is a story that has been developing for quite some time. The concern is not necessarily the app itself but that TikTok is owned by a company called ByteDance, which is domiciled and headquartered inside of China,” Haugli said. “The concern…

Continue Reading

WednesdayMar 01, 2023 12:54 pm

QualityStocksNewsBreaks – SideChannel Inc. (SDCH) CEO Weighs In on Defending Against Zero-Day Attacks

SideChannel (OTCQB: SDCH) CEO and cybersecurity expert Brian Haugli was quoted in a recent IT Brew article focused on preparing for zero-day attacks. According to the article, titled “What’s a Zero-Day Attack (and How Can You Prepare for One)?”, these types of attacks occur when an attacker finds and exploits a weakness that is unknown to the vendor responsible for patching it. The weakness might be in software, operating systems, browsers, Java logging utilities or anywhere else, and companies have no time (hence the term “zero day”) to fix the problem. Instead, the article notes, a race begins between patch-makers and…

Continue Reading

WednesdayMar 01, 2023 12:30 pm

QualityStocksNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Focus of Chardan Capital Research Report; Maintains Buy Rating, Updates Price Target

Freight Technologies (NASDAQ: FRGT), a technology company whose custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine-learning that offers a real-time portal for B2B cross-border shipping and domestic shipping within the USMCA region, is featured in a recent Chardan Capital research report. In the report, Chardan Capital, a leading investment and research firm, maintained its buy rating on FRGT company shares and lowered the price target to $2. According to the announcement, Freight Technologies is pleased to receive the latest endorsement, which reflects the company's ongoing efforts to expand its operations and is an indication of continued confidence…

Continue Reading

TuesdayFeb 28, 2023 2:02 pm

QualityStocksNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Well Poised Following Successful Capital Raise

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, recently announced that it had successfully concluded its fully underwritten primary share placement. “The offering, which consisted in Eloro issuing 3,466,540 primary shares at a price of C$3.15 per share, raised total gross proceeds of C$10,919,570; the figure also includes shares granted as part of the over-allotment option granted to underwriters… Eloro Resources has revealed that the net proceeds derived from the offering will be destined toward exploration and development purposes at the…

Continue Reading

TuesdayFeb 28, 2023 11:27 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Releases Progress Updates on Two Clinical Development Programs

Cybin (NEO: CYBN) (NYSE American: CYBN),a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), is reporting on its two lead clinical development programs: CYB003, a proprietary deuterated psilocybin analog for the potential treatment of major depressive disorder (“MDD”), and CYB004, a proprietary deuterated N,N-dimethyltryptamine molecule being developed for the potential treatment of generalized anxiety disorder (“GAD”). According to the announcement, interim data from the CYB003 phase 1/2a study exhibited rapid and short-acting effects; strong psychedelic effects at low doses; and a positive safety and tolerability profile. The company anticipates having top-line efficacy data by late Q3 2023. In addition, initial findings…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered